Bixiye
QP100-22 Service Area Expansion for Minnesota Health Care Programs (MHCP)
Taariikhda uu dhaqangalayo Barnaamijka: Nov 23, 2022
Natiijooyinka Raadinta
Soo bandhiga 1181 - 1190 ee natiijooyinka 4296
Bixiye
P25R1-20 Children’s Therapeutic Services and Supports (CTSS) Prior Authorization Requirement
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2023
Bixiye
QP112R1-20 Changes to Electronic Funds Transfer Processes
Taariikhda uu dhaqangalayo Barnaamijka: 22, Feb 2023
Bixiye
QP11-23 Commercial Pharmacy Benefit Exclusion for Cimzia®
Taariikhda uu dhaqangalayo Barnaamijka: 22, Feb 2023
Bixiye
QP12-23 Change in Prior Authorization Process for Experimental or Investigative Services
Taariikhda uu dhaqangalayo Barnaamijka: 22, Feb 2023
Bixiye
QP6-23 Commercial Pharmacy Benefit Exclusion for Briumvi™, Hemgenix®, Rebyota™, and Sunlenca® Injection
Taariikhda uu dhaqangalayo Barnaamijka: 08, Feb 2023
Bixiye
QP7-23 MHCP Pharmacy Benefit Exclusion for Briumvi™, Hemgenix®, Lunsumio™, Rebyota™, Sunlenca® Injection, and Vivimusta
Taariikhda uu dhaqangalayo Barnaamijka: 08, Feb 2023
Bixiye
QP8-23 Commercial Formulary Addition for Growth Hormone Therapeutic Class: Genotropin® (somatropin)
Taariikhda uu dhaqangalayo Barnaamijka: 08, Feb 2023